Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06078956 · ClinicalTrials.gov registry record · NA
ABL90 Flex Plus Method Comparison Study_Adults
A NA study, sponsored by Radiometer Medical ApS.
- Completed
- Registry status
- NA
- Development phase
- 754
- Enrollment target
NCT06078956 is a NA study that has completed, run by Radiometer Medical ApS. The registered enrollment target is 754 participants.
The verdict
NCT06078956, a NA study, has completed, sponsored by Radiometer Medical ApS.
- COMPLETED
- Registry status
- NA
- Development phase
- 754 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to validate performance claims for method comparison for the ABL90 FLEX PLUS for pH, pCO2, pO2, cCa2+, cCl-, cK+, cNa+, cGlu, cLac, ctHb, sO2, FO2Hb, FMetHb, FCOHb and FHHb in heparinized whole blood in a Point of Care (POC) setting.
Interventions
- DEVICE Measuring of analytes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 754 participants |
| Start Date | 2023-07-08 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06078956
The ClinicalTrials.gov registry entry for NCT06078956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 754 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiometer Medical ApS, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Measuring of analytes is the first listed.
NCT06078956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06078956 about?
NCT06078956 is a clinical study titled "ABL90 Flex Plus Method Comparison Study_Adults". The goal of this clinical trial is to validate performance claims for method comparison for the ABL90 FLEX PLUS for pH, pCO2, pO2, cCa2+, cCl-, cK+, cNa+, cGlu, cLac, ctHb, sO2, FO2Hb, FMetHb, FCOHb and FHHb in heparinized whole blood in a Point of Care (POC) setting.
What is the current status of trial NCT06078956?
This trial is currently completed. It is a NA study. The enrollment target is 754 participants. The study started on 2023-07-08. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT06078956?
The interventions under investigation include: Measuring of analytes (DEVICE).
Who is sponsoring clinical trial NCT06078956?
This trial is sponsored by Radiometer Medical ApS, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.